SYM-HGMNCT07510984
Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Trial terminated Sponsor's reason: Enrollment stopped after an unplanned interim analysis showed a statistically significant result for the primary endpoint; further recruitment was not expected to alter the conclusion Show 6 more changesShow less
- Eligibility criteria expanded, about 20 words
- Final enrollment: 422 participants (planned 721)
- Primary completion date changed from estimate of Mar 24, 2027 to Sep 30, 2026
- Secondary endpoints: details revised at 3 of 3 entries
- Study description revised
- Site details revised
- Notable Primary endpoint(s) modified
- Secondary endpoints revised (3)
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Dysphagia Symptom Burdon (EAT-10 und SSQ)
Timeframe: Baseline (prior to gastroscopy; single assessment at enrollment)
Secondary (3)
HGM & Dyspepsia (GSRS)
Type of Dysphagia (Oropharyngeal vs Esophageal)
Health-Related Quality of Life (HRQoL)
Arms and interventions
HGM present
Participants with endoscopic evidence of heterotrophic gastric mucosa
No HGM
Participants without endoscopic evidence of heterotrophic gastric mucosa
Sites
1 site in 1 country
- Knappschaftskrankenhaus BottropBottrop, North Rhine-Westphalia, Germany